Skip to content

Clinical trials

Dementia trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Country / region: Austria Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20071
20101
20111
20121
20131
20141
20161
20171
20182
20193
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Graz4
Avraham Pharmaceuticals Ltd2
Affiris AG1
AstraZeneca1
Axon Neuroscience SE1
Danube University Krems1
Eisai Co., Ltd.1
Finnish Institute for Health and Welfare1
GE Healthcare1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia18
Alzheimer Disease9
Cognitive Dysfunction8
Memory Disorders3
Brain Diseases2
Mental Disorders2
Nervous System Diseases2
Neurodegenerative Diseases2
Anxiety Disorders1
Central Nervous System Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.